Sareum Holdings (SAR)


Latest News

Sareum swings to H1 pretax profit

Sareum Holdings has swung to an H1 pretax profit of 573,000, from a year-ago loss of 568,000. Revenue was nil. "With Chk...

Half-year Results

RNS Number: 2451X Sareum Holdings PLC 20 February 2017 (AIM:SAR) 20 February 2017 SAREUM HOLDINGS PLC ("Sareum" or "the Company") HALF-YEARLY RESULTS FOR THE SIX MONTHS ENDED 31 DECEMBER 2016 Sareum Holdings plc (AIM: SAR), the specialist cancer drug discovery and development business, announces its half-yearly results...

Notice of Interim Results

RNS Number: 3549W Sareum Holdings PLC 09 February 2017 (AIM: SAR) 9 February 2017 SAREUM HOLDINGS PLC ("Sareum" or "the Company") Notice of Interim Results Sareum Holdings plc (AIM:SAR), the specialist cancer drug discovery and development company, announces that it expects to release its interim results for the six months to 31 December 2016...

Milestone Payment from Chk1 Licence Agreement

RNS Number: 6485T Sareum Holdings PLC 09 January 2017 (AIM: SAR) 9 January 2016 SAREUM HOLDINGS PLC ("Sareum" or "the Company") Milestone Payment from Chk1 Licence Agreement Sareum Holdings plc (AIM:SAR), the specialist cancer drug discovery and development company, is pleased to announce the attainment of a US$2.0 million success mile...

All News

20-02-17Sareum swings to H1 pretax profitStockMarketWire
20-02-17Half-year ResultsRNS
09-02-17Notice of Interim ResultsRNS
09-01-17Milestone Payment from Chk1 Licence AgreementRNS
22-12-16Result of General MeetingRNS
15-12-16Result of AGMRNS
06-12-16Directors' Remuneration & General MeetingRNS
29-11-16Sareum to Present at AACR-NCI-EORTC ConferenceRNS
21-11-16Notice of AGMRNS
02-11-16Sareum Holdings narrows FY pretax lossStockMarketWire
02-11-16Final ResultsRNS
24-10-16Sareum says TYK2 feasibility study successfulStockMarketWire
24-10-16Successful Outcome from TYK2 Feasibility StudyRNS
17-10-16Sareum notes Japan, Singapore Patent GrantsStockMarketWire
17-10-16Japan and Singapore Patent GrantsRNS
27-09-16Banks keep FTSE in the red StockMarketWire
27-09-16Licence agreement for Chk1 Inhibitor CCT245737RNS
03-08-16Sareum confirms patent grants for Aurora+FLT3StockMarketWire
03-08-16China & HK Patent Grants for Sareum's Aurora+FLT3RNS
28-07-16Sareum comments on share-price moveStockMarketWire
28-07-16Movement in share priceRNS
23-05-16Clinical Trials CHK1 Inhibitor CCT245737 to OpenRNS
17-05-16Sareum appoints Stephen Parker as chairmanStockMarketWire
17-05-16Change of DirectorRNS
05-04-16FTSE falls on resources as Wall St, Europe dropStockMarketWire
05-04-16Should You Buy Blinkx Plc, Electrocomponents plc And Sareum Holdings Plc On Today’s News?Motley Fool
05-04-16Sareum's winStockMarketWire
05-04-16FTSE extends falls on resources; Europe tumblesStockMarketWire
05-04-16CHK1 Approved for Clinical TrialsRNS
24-03-16Sareum raises GBP1.1m via placingStockMarketWire
17-03-16Why Traders Are Moving Goodwin plc And Sareum Holdings Plc TodayMotley Fool
14-03-16Issue of OptionsRNS
10-03-16Sareum notes share price movementStockMarketWire
10-03-16Share price movementRNS
24-02-16Sareum Holdings narrows H1 pretax lossStockMarketWire
24-02-16Research & Co-Development Collaborations UpdateRNS
24-02-16Half-Yearly Results for December 2015RNS
01-02-16Sareum's clinical trial submissions trigger milestoneStockMarketWire
01-02-16CHK1 Clinical Trial Application SubmissionsRNS

RSS feeds

  • Editorial news feed for LSE:SAR Editorial
  • Regulatory news feed for LSE:SAR Regulatory